New
In this study, researchers are going to evaluate the efficacy and safety of narrow-band UV phototherapy in the treatment of vitiligo as well as impact on quality of life. Study participants must be over 18 years old and seeking treatment for vitiligo located on both sides of the body. Participants will receive
Participation involves:
- Free NB-UVB phototherapy treatments three times per week for six months.
- Questionnaires on how vitiligo affects the quality of your life.
- Small skin biopsies of your skin.
Principal investigator for study is Ginette Okoye, MD, Assistant Professor, Director of Ethnic Skin Research Program, Johns Hopkins University. ClinicalTrials.gov Identifier NCT02506101. For more information, please call 410-502-SKIN or email ctrep@jhmi.edu
FAQ: Why clinical trials are needed? Follow this link to find out more about clinical trials and why they are so vital.
FAQOther Questions
- Isn't it just a cosmetic disorder?
Contrary to popular belief, vitiligo is not a cosmetic disorder but a systemic disease affecting the largest body organ and other vital systems, with multiple comorbidities. Fo...
- What is vitiligo?
Vitiligo (pronounced vit-ill-EYE-go) is a relatively common skin disease characterized by smooth, white, painless spots or patches on various parts of the body and hairs above i...
- Will it spread?
Vitiligo activity may vary considerably from person to person. In a good number of patients the disease goes on for 3-4 years and then it settles down, with one or two stubborn...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.